People with hypertension should not normally receive simultaneous Angiotensin converting enzyme inhibitors (ACEi) and Angiotensin II receptor blockers (ARB).
You are not authorised to view the comments for this indicator.
If you wish to view comments and/or contribute, please Register.
Registration does not guarantee access.
Our Research Group will review and process your registration. You will receive an email notification about the status of your registration.